http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112538434-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2602-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C51-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P7-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 |
classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-77 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C51-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P7-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C59-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-14 |
filingDate | 2020-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2022-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2022-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-112538434-B |
titleOfInvention | Sea anemone symbiotic fungus SYSU-MS5127 and its fermentation compounds and applications |
abstract | The invention belongs to the technical field of fungal extraction compounds, in particular to sea anemone symbiotic fungus SYSU-MS5127 and its fermentation compound and application. A kind of sea anemone symbiotic fungus Fusarium graminearum (Fusarium graminearum) fungal strain SYSU-MS5127 of the present invention can metabolize and synthesize the compound Fusarielin M, and through experimental verification, the compound Fusarielin M can reduce the inflammatory factors NO, NO, The expression of PGE 2 has significant anti-inflammatory activity, and experiments have proved that it has no cytotoxicity and high safety, and has a good application prospect in the preparation and development of anti-inflammatory drugs. |
priorityDate | 2020-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 26.